Michael Mcneil's Insider Trades & SAST Disclosures
Michael Mcneil's most recent trade in Sanara MedTech Inc was a trade of 1,486 Common Stock done . Disclosure was reported to the exchange on March 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Mcneil.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sanara MedTech Inc | Michael D. McNeil | Ch. Acct. & Ch. Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 1,486 | 32,521 | - | 0 | Common Stock | |
| Sanara MedTech Inc | Michael D. McNeil | Ch. Acct. & Ch. Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,037 | 31,035 | - | 0 | Common Stock | |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,650 | 25,998 | - | 0 | Common Stock | |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.96 per share. | 01 Mar 2024 | 687 | 21,947 | - | 39.0 | 26,766 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.96 per share. | 01 Mar 2024 | 599 | 21,348 | - | 39.0 | 23,337 | Common Stock |
| Sanara MedTech Inc | Michael McNeil D. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.72 per share. | 01 Feb 2024 | 391 | 22,634 | - | 33.7 | 13,185 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 12 Apr 2023 | 1,000 | 23,025 | - | 6 | 6,000 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 1,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 17 Mar 2023 | 658 | 22,810 | - | 40.5 | 26,649 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.50 per share. | 17 Mar 2023 | 532 | 22,025 | - | 41.5 | 22,078 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.30 per share. | 17 Mar 2023 | 253 | 22,557 | - | 43.3 | 10,955 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 4,217 | 23,468 | - | 0 | Common Stock | |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.79 per share. | 02 Dec 2022 | 865 | 19,504 | - | 30.8 | 26,633 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.97 per share. | 02 Dec 2022 | 253 | 19,251 | - | 23.0 | 5,811 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 6,547 | 20,369 | - | 0 | Common Stock | |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 3,106 | 13,822 | - | 0 | Common Stock | |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 864 | 11,020 | - | 45.7 | 39,459 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 152 | 10,868 | - | 45.7 | 6,942 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.53 per share. | 16 Dec 2021 | 152 | 10,716 | - | 35.5 | 5,401 | Common Stock |
| Sanara MedTech Inc | Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,247 | 11,884 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges